Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results for RTA
Abstract Number: H21
A TEAMING APPROACH TO IMPROVE THE MORBIDITY & MORTALITY CONFERENCE
SHM Converge 2022
Background: Morbidity and Mortality (M&M) conferences are common practice among internal medicine (IM) residency programs, but their effect on education and patient safety (PS) is inconsistent.[1,2] Existing research reports have struggled to identify best practices for implementing M&M conferences due to inherent variability in personnel and adverse event analysis processes. We need interventions that account [...]
Abstract Number: N10
IS ATRIAL FIBRILLATION AN INDEPENDENT RISK FACTOR FOR SEVERE COVID-19 INFECTION?
SHM Converge 2022
Background: Atrial fibrillation (AF) is condition associated with increased risk of death in multiple populations (1). The association between AF and COVID-19 infection has started to be explored, but largely in specific geographic locations and/or within the context of the hospitalization (2). By understanding the relationship between COVID-19 and AF, providers may be better supported [...]
Abstract Number: N27
A RARE COMPLICATION OF CIRRHOSIS: TRANSUDATIVE CHYLOTHORAX
SHM Converge 2022
Case Presentation: A 57-year-old male with history of non-alcoholic steatohepatitis (NASH) cirrhosis complicated by recurrent hepatic hydrothorax (requiring approximately 15 thoracenteses) presented with dyspnea. Admission chest x-ray and subsequent computed tomography (CT) scan revealed a large pleural effusion with collapse of the right lower lobe. He underwent thoracentesis with removal of two liters of pink, [...]
Oral Presentations
Abstract Number: 0007
PRIOR GLP-1 AGONIST USE IS NOT ASSOCIATED WITH ADVERSE INPATIENT QUALITY OUTCOMES: A PROPENSITY-MATCHED ANALYSIS
SHM Converge 2025
Background: Glucagon-like peptide-1 (GLP-1) agonists are increasingly prescribed for obesity and type 2 diabetes, demonstrating efficacy in weight loss and glycemic control [1-3]. Beyond metabolic effects, these medications show protective effects against renal disease progression and reduce major adverse cardiovascular events [4]. GLP-1 agonists influence body composition through effects on both fat mass and fat-free [...]
Oral Presentations
Abstract Number: 0012
INNOVATING PATIENT-CENTERED ELECTRONIC COMMUNICATION: REAL-TIME ACCESS TO THE INPATIENT CARE PLAN
SHM Converge 2025
Background: Hospitalized patients and their families often face challenges in accessing and understanding developments in care plans, test results, and interdisciplinary decisions made during their stay. This knowledge gap causes anxiety, confusion, and missed opportunities for shared decision-making. Enhanced interdisciplinary communication and transparency with patients positively impacts patient satisfaction, readmission rates, patient safety and adherence [...]
Abstract Number: 0032
IMPROVING MORTALITY OUTCOMES: A DATA-DRIVEN, HOSPITALIST-LED APPROACH TO ENHANCE QUALITY AND RANKINGS
SHM Converge 2025
Background: Mortality rates are a critical quality metric for hospitals, influencing both clinical outcomes and institutional reputation. The Centers for Medicare and Medicaid Services (CMS) incorporates 30-day mortality rates into its Value-Based Purchasing (VBP) program and Star Ratings, directly impacting hospital reimbursement and public perception. Similarly, U.S. News & World Report factors 30-day mortality into [...]
Abstract Number: 0099
THE SILENT RISK: EXPLORING ANTIDEPRESSANT POISONING-RELATED MORTALITY IN THE U.S. THROUGH CDC WONDER DATA: A DEEP DIVE INTO DATA (1999-2020)
SHM Converge 2025
Background: The overdose epidemic in the United States has seen a significant rise in deaths associated with antidepressants in the last two decades. This study examines mortality trends related to antidepressants in adults aged >25 years between 1999 and 2020 across various demographics. Methods: Analysis of poisoning by anti-depressants-related deaths in the US from the [...]
Abstract Number: 0108
UNVEILING HYPOGLYCEMIA IN THE HOSPITAL: EXPLORING RISKS AND OUTCOMES OF HYPOGLYCEMIA AMONG 54,500+ HOSPITALIZED PATIENTS
SHM Converge 2025
Background: Inpatient hypoglycemia (HG) is common and often avoidable, associated with poor outcomes and high costs, and its prevention reflects hospital performance. We investigated its risk factors and impact on mortality, hospital length of stay (LOS), charges, and readmissions. We defined HG as glucose ≤40 mg/dl (severe), >40 – ≤70 mg/dl (moderate), or euglycemia >70 [...]
Abstract Number: 0114
THE EFFECT OF SEPSIS ALERT SYSTEMS ON MORTALITY: A SYSTEMATIC REVIEW AND META ANALYSIS
SHM Converge 2025
Background: The Surviving Sepsis Campaign strongly recommends that all hospitals screen for sepsis as part of performance improvement. The effect of screening for sepsis on mortality, length of stay, and time to antibiotics is uncertain. Methods: A systematic literature search was conducted using Cochrane Library, Google Scholar, Ovid Embase, Ovid Medline, Scopus, and Web of [...]
Abstract Number: 0117
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF INTRAVENOUS ACETAMINOPHEN USE FOR PAIN MANAGEMENT IN SMALL BOWEL OBSTRUCTION- INTERIM ANALYSIS OF FEASIBILITY AND OUTCOMES
SHM Converge 2025
Background: Patients admitted for nonsurgical management of small bowel obstruction (SBO) often receive intravenous (IV) opioids for pain relief. However, given the opioid crisis and the potential for opioids to hinder recovery and contribute to ileus, exploring alternative analgesics is crucial. This randomized controlled trial (RCT) evaluates the efficacy of IV acetaminophen for pain management [...]
‹ Previous 1 … 16 17 18 19 20 Next ›
  • This Week

  • This Month

  • All Time

  • This Week

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • This Month

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • All Time

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • ADDERALL INDUCED ISCHEMIC COLITIS

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE

  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations

  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN

© Society of Hospital Medicine | All Rights Reserved | Privacy Policy
Page load link
Go to Top